National Institutes of Health Grants Phase I SBIR Award to CytoSorbents to Test Novel …
Goal is to advance new combined blood purification technologies to treat Gram negative sepsis – a deadly global killer. PRINCETON, N.J., Oct. 31, …
See more –> Source
